[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@OliveDrabGreen OD Green

OD Green posts on X about $amrn, market cap, $285m, core the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

• X Week XXX -XX%
• X Month XXXXX -XX%
• X Months XXXXXX +9.60%
• X Year XXXXXXX +173%

Mentions: X #

• X Week X -XX%
• X Month XX -XX%
• X Months XXX +94%
• X Year XXX +76%

Followers: XXX #

• X Week XXX +1.30%
• X Month XXX +1.30%
• X Months XXX +18%
• X Year XXX +64%

CreatorRank: undefined #

Social Influence

Social topic influence $amrn 33.33%, market cap 33.33%, $285m 33.33%, core XXXXX%

Top accounts mentioned or mentioned by @pulte @rnaudbertrand @ihaveamirror

Top Social Posts

Top posts by engagements in the last XX hours

"It is laughable that Amarin $AMRN is trading with a market cap just above its $285m in cash (significant discount to value when considering NOL value and inventory). Analysis of Amarin as essentially a "5-year warrant" on its core assetVASCEPA/VAZKEPA (icosapent ethyl)without meaningful time-value premium is spot-on and aligns closely with the current financial snapshot. With a market cap hovering around $XXX million net cash position exceeding $XXX million zero debt and a pivot toward cash flow positivity the equity appears to embed minimal value for the drug's ongoing U.S. stability ex-U.S."
X Link 2025-12-09T18:55Z XXX followers, XX engagements